Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin
DexCom, Inc. (NASDAQ: DXCM) Delayed: 68.92 -0.15 (0.22%)
Previous Close $69.07    52 Week High $96.38 
Open $70.24    52 Week Low $47.92 
Day High $70.27    P/E N/A 
Day Low $68.72    EPS $-0.42 
Volume 6,347,610